awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35226507-6ECD2727-DA57-43A4-AC84-E55E1E575310
Q35226507-6ECD2727-DA57-43A4-AC84-E55E1E575310
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35226507-6ECD2727-DA57-43A4-AC84-E55E1E575310
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors
P2860
Q35226507-6ECD2727-DA57-43A4-AC84-E55E1E575310
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35226507-6ECD2727-DA57-43A4-AC84-E55E1E575310
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e31852b85a63d0c318652135a2aeb0dcb61911f1
P2860
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.